370 related articles for article (PubMed ID: 26007605)
1. Metal nanoparticles: a theranostic nanotool against cancer.
Sharma H; Mishra PK; Talegaonkar S; Vaidya B
Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold‑iron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer theranostics.
Ghorbani M; Bigdeli B; Jalili-Baleh L; Baharifar H; Akrami M; Dehghani S; Goliaei B; Amani A; Lotfabadi A; Rashedi H; Haririan I; Alam NR; Hamedani MP; Khoobi M
Eur J Pharm Sci; 2018 Mar; 114():175-188. PubMed ID: 29248558
[TBL] [Abstract][Full Text] [Related]
3. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
4. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
[TBL] [Abstract][Full Text] [Related]
5. Chemistry for oncotheranostic gold nanoparticles.
Trouiller AJ; Hebié S; El Bahhaj F; Napporn TW; Bertrand P
Eur J Med Chem; 2015 Jun; 99():92-112. PubMed ID: 26057706
[TBL] [Abstract][Full Text] [Related]
6. Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging.
Tian F; Conde J; Bao C; Chen Y; Curtin J; Cui D
Biomaterials; 2016 Nov; 106():87-97. PubMed ID: 27552319
[TBL] [Abstract][Full Text] [Related]
7. Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
Kumar R; Shin WS; Sunwoo K; Kim WY; Koo S; Bhuniya S; Kim JS
Chem Soc Rev; 2015 Oct; 44(19):6670-83. PubMed ID: 26118960
[TBL] [Abstract][Full Text] [Related]
8. Gold Nanoparticles as Targeted Delivery Systems and Theranostic Agents in Cancer Therapy.
Mioc A; Mioc M; Ghiulai R; Voicu M; Racoviceanu R; Trandafirescu C; Dehelean C; Coricovac D; Soica C
Curr Med Chem; 2019; 26(35):6493-6513. PubMed ID: 31057102
[TBL] [Abstract][Full Text] [Related]
9. Metal-derived nanoparticles in tumor theranostics: Potential and limitations.
Kuchur OA; Tsymbal SA; Shestovskaya MV; Serov NS; Dukhinova MS; Shtil AA
J Inorg Biochem; 2020 Aug; 209():111117. PubMed ID: 32473483
[TBL] [Abstract][Full Text] [Related]
10. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional gold-based nanocomposites for theranostics.
Dykman LA; Khlebtsov NG
Biomaterials; 2016 Nov; 108():13-34. PubMed ID: 27614818
[TBL] [Abstract][Full Text] [Related]
12. Gold Nanoparticles; Potential Nanotheranostic Agent in Breast Cancer: A Comprehensive Review with Systematic Search Strategy.
Khandker SS; Shakil MS; Hossen MS
Curr Drug Metab; 2020; 21(8):579-598. PubMed ID: 32520684
[TBL] [Abstract][Full Text] [Related]
13. Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy.
Luo S; Yang X; Shi C
Curr Med Chem; 2016; 23(5):483-97. PubMed ID: 26695513
[TBL] [Abstract][Full Text] [Related]
14. Theranostic potential of gold nanoparticle-protein agglomerates.
Sanpui P; Paul A; Chattopadhyay A
Nanoscale; 2015 Nov; 7(44):18411-23. PubMed ID: 26508277
[TBL] [Abstract][Full Text] [Related]
15. Cancer nanotheranostics: Strategies, promises and impediments.
Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
[TBL] [Abstract][Full Text] [Related]
16. Rational Design of Biomolecular Templates for Synthesizing Multifunctional Noble Metal Nanoclusters toward Personalized Theranostic Applications.
Yu Y; Mok BY; Loh XJ; Tan YN
Adv Healthc Mater; 2016 Aug; 5(15):1844-59. PubMed ID: 27377035
[TBL] [Abstract][Full Text] [Related]
17. Bioinspired approaches for cancer nanotheranostics.
Evangelopoulos M; Tasciotti E
Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
[No Abstract] [Full Text] [Related]
18. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
19. Theranostic lipid nanoparticles for cancer medicine.
Charron DM; Chen J; Zheng G
Cancer Treat Res; 2015; 166():103-27. PubMed ID: 25895866
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale theranostics for physical stimulus-responsive cancer therapies.
Chen Q; Ke H; Dai Z; Liu Z
Biomaterials; 2015 Dec; 73():214-30. PubMed ID: 26410788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
